INTRODUCTION
The cyclic interconversions of vitamin K to its hydroquinone, to vitamin K epoxide and back to vitamin K which take place in the rough endoplasmic reticulum of hepatocytes is known as the vitamin K cycle. The cycle provides the energy for the posttranslational carboxylation reaction that converts glutamyl residues in substrate proteins (e.g. clotting factors) into ycarboxyglutamates (see refs. [1] and [2] for reviews).
The two reduction steps, i.e. vitamin K epoxide to vitamin K and vitamin K to vitamin K hydroquinone, are catalysed by the enzyme vitamin K epoxide reductase. In vitro, the enzyme needs a dithiol to supply reducing equivalents, suggesting the presence of redox-active thiol groups in its catalytic centre [3] . The 4- hydroxycoumarin anticoagulants such as warfarin are potent inhibitors of this reductase. These compounds bind tightly, essentially irreversibly, to the oxidized enzyme thereby hampering the dithiol-dependent re-activation of the enzyme. On enzyme activation the bound anticoagulant dissociates [4] [5] [6] . Therefore the dithiol reducing agent plays a central role in the intrinsic activity of oral anticoagulants [6] .
The nature of the endogenous dithiol supplier is not yet unequivocally established; reduced thioredoxin [7, 8] and reduced protein disulphide isomerase (PDI) [9] have been suggested as candidates. Both are water-soluble polypeptides (12000 and 57000 Da respectively) containing redox-active pairs of thiols and are involved in various oxidoreduction reactions [10] [11] [12] . However, although abundantly present in cytosol and the lumen ofthe endoplasmic reticulum [13] , detergent is needed to stimulate the in vitro microsomal vitamin K (epoxide) reductase activity with thioredoxin and/or PDI [9, 14] Microsomal vitamin K epoxide reductase activity was assayed as described [6] . The reaction mixture contained (in order of addition) 0.4 mg of microsomal protein, vitamin K epoxide (85 ,uM, 2 ,ul of the 1 00 Triton X-100 stock solution), 10 ,1 of DMSO with or without LA and Tris buffer to make a final volume of 0.1 ml. After a preincubation of 5 min at 30°C, the reaction was started with either DTT (5 ,ul of a DTT solution in Tris buffer) or NADH (5 ,ul of a NADH solution in Tris buffer) when LA served as the dithiol donor. The reaction was allowed to proceed for 5-10 min and the vitamin K formed was assayed by h.p.l.c. [6] . For the case when LAH2 served as the dithiol cofactor, the reaction was started by the addition of 10 ul of LAH2 in DMSO. To study the effect of Triton X-100 on the reductase reactions, a stock solution of vitamin K epoxide in propan-2-ol (2 mg/ml) was used as the substrate. The detergent was the last component to be added to the reaction mixture. LA reductase activity was assayed as follows: a reaction mixture containing, in a total volume of 0.1 ml, 0.4 mg of microsomal protein or 0.1 unit of LA dehydrogenase, 10 1u of LA in DMSO and Tris buffer was preincubated for 5 min at 30 'C. The reaction was started by the addition of NADH in 5 ,ul of Tris buffer. After an incubation period of 5-10 min, the reaction was stopped by the addition of 0.1 ml of propan-2-ol. The supernatant (20 ,tl) was mixed with 1 ml of 0.40% Ellman's reagent in phosphate buffer, pH 7.0. The absorption at 412 nm was recorded after 10 min. DTT was used to construct a calibration curve.
The kinetic constants, Km and V., were determined by fitting the data to the Michaelis-Menten equation using the software package GPAD (GraphPad Software).
Pilot experiments showed that LA/NADH-stimulated microsomal vitamin K epoxide reduction is sensitive to detergent (Triton X-100); 0.05% Triton X-100 appeared to reduce the LA/NADH-stimulated activity by 70-80 % compared with that in standard conditions (0.020% Triton X-100). In contrast, the DTT-stimulated reaction was enhanced about 1.5-fold. To investigate further the effect of Triton X-100, the standard assay procedure was adapted by using vitamin K epoxide in propan-2-ol (see the Experimental section). Under these conditions, the DTT-stimulated vitamin K epoxide reductase activity was about 0.6 as high (results not shown). The detergent was found to inhibit the LA/NADH-as well as the DTT-stimulated reaction, the former system being much more sensitive: 0.01 % Triton X-100 caused 400% inhibition of the reaction stimulated by LA/ NADH but hardly affected the DTT-stimulated one (Figure 1 ). LA/NADH-stimulated vitamin K epoxide reduction was as sensitive to warfarin inhibition as the DTT-stimulated reaction (Table 2) . Microsomes were subjected to subfractionation into smooth and rough microsomes; both enzyme systems, vitamin K epoxide reductase and LA reductase, were recovered mainly in the rough microsomes (Table 3) . (1 mM) were in the presence of 0.05% Triton X-100, and those with LA/NADH (10 and 5 mM respectively) in the presence of 0.02% Triton X-100. LA reductase was estimated using 10 mM LA, 5 mM NADH and 0.05% Triton X-100. An inhibition pattern comparable with the DTT-stimulated reaction was seen with LAH2 as the dithiol cofactor ( Figure 1 ) and for LA/NADH with additional LA reductase activity (LA dehydrogenase or cytosolic fraction) (results not shown). The microsomal NADH-dependent LA reductase was stimulated (Figure 1 ).
The comparative enzyme kinetics of the DTT-and LAH2-stimulated microsomal vitamin K epoxide reductase are presented in Table 4 [14, 19] . The effect of salicylate in the various reactions was therefore studied. The results are summarized in 
DISCUSSION
One of the main results of the present study is the observation that liver microsomes contain LA reductase activity capable of transferring reducing equivalents from NADH via LAH2 to the reductase(s) of the vitamin K cycle. To conclude that LAH2 is the endogenous dithiol cofactor of vitamin K (epoxide) reductase is as yet premature, but the study does provide evidence in its favour. First, the incubation experiments in the presence of Triton X-100 suggest that there is an organized relationship between NADH-dependent LA reduction and vitamin K epoxide reductase. As has been reported by others [14] , detergents have deleterious effects on in vitro microsomal vitamin K epoxide reduction, suggesting a requirement for a lipidic (membranous) environment. The LA/NADH-stimulated reduction of the epoxide appears to be far more sensitive to detergent than the DTT-stimulated reaction. The higher sensitivity is neither due to inhibition of the microsomal LA reductase (in fact, LA reduction is enhanced) nor to a reduced accessibility of vitamin K epoxide reductase to LAH2. A likely explanation is that the two systems, LA reductase and vitamin K epoxide reductase, are in close association within the microsomes. Detergent, even when present in small amounts, affects the complex, thereby preventing optimal donation of LAH2. The fact that, like vitamin K epoxide reductase, LA reductase is also located in the rough microsomes (Table 3 ) supports the suggestion of systems being associated. The apparent discrepancy of the effect of Triton X-100 on DTTstimulated vitamin K epoxide reductase needs some comment; the activation that is seen when Triton X-100 is added to the reaction mixture as the vehicle for the epoxide substrate is probably associated with substrate accessibility to the enzyme [20] . Why this effect is absent from the LAH2-stimulated reaction (Table 4) The relatively high Km values of the system for LA and NADH can be put forward as a point against the argument. However, one should bear in mind that the enzyme kinetics experiments were performed in crude microsomal preparations using the rather water-insoluble substrates, LA and LAH2. However, the Km of LA for heart LA dehydrogenase has been reported to be about 1 mM [21] which is comparable with our findings. Furthermore, if LA reductase and vitamin K epoxide reductase are indeed coupled, optimal transfer of LAH2 should be ensured. LA/NADH-stimulated microsomal vitamin K epoxide reduction has also been found in human liver [22] and bovine liver microsomes.
Recently, Soute et al. [9] postulated that vitamin K (epoxide) reduction is coupled to the formation of disulphide bridges in nascent secretory proteins. The coupling is suggested to be mediated via the redox-active peptides PDI and thioredoxin. The model seems attractive, for instance, it would provide an explanation for the apparent high vitamin K epoxide reductase levels in secretory organs such as pancreas and salivary gland [23] . However, the experimental evidence for the model must be seriously questioned. To support vitamin K epoxide reductase by the suggested pathway, the (bovine) microsomal reaction system has to be solubilized almost completely, indicating that neither thioredoxin nor PDI would have easy access to the membraneembedded reductase [9] . Furthermore, all the elements have to be added to the system even though PDI has been shown to be abundantly present in the lumen of the endoplasmic reticulum [13, 24] [it should be noted that LA is readily washed out during microsome preparation (H. H. W. Thijssen, Y. P. G. Janssen and L. T. M. Vervoort, unpublished work)]. In addition, if the vitamin K cycle has a role in protein synthesis as proposed, warfarin therapy would probably encounter serious side effects.
Neither warfarin nor salicylate had a direct effect on LA reductase, whereas their inhibition of vitamin K epoxide reductase was by a direct effect on the enzyme. Recently, it was argued that salicylate inhibition involved interruption of the transfer of cytosolic reducing equivalents to the microsomal vitamin K epoxide reductase [14] . This was concluded from the observation that, with fresh cytosolic fraction as donor of reducing equivalents, this enzyme is much more sensitive to salicylate. However, a more likely explanation for this observation can be found in the fact that the salicylate inhibition depends on the concentration of the dithiol reducing agent [19] (H. H. W. Thijssen, Y. P. G. Janssen and H. T. M. Vervoort, unpublished work). The cytosol-stimulated reductase activity was less than 10 % ofthe DTT-stimulated reaction [14] , indicating low levels of the undefined cytosolic dithiol reducing agent (LAH2?)
The well-known biochemical function of lipoic acid is to transfer acyl groups from thiamin to CoA. Reoxidation of the reduced lipoic acid is mediated by the flavoprotein LA dehydrogenase. The reactions are involved in the oxidation of pyruvate and other a-oxo acids (e.g. a-oxoglutarate) by the pyruvate (a-oxoglutarate) dehydrogenase complex [25] . In this complex, lipoic acid is linked via an amide bond to a lysine residue of lipoate acetyltransferase suggesting no cellular free LA. On the other hand, at least 10 % of total rat hepatocyte LA dehydrogenase activity has been reported to be cytosolic and to differ from mitochondrial LA dehydrogenase [26] , suggesting cellular functions for LA and LAH2 other than the mitochondrial ones, such as the provision of the vitamin K cycle with reducing equivalents.
